Cancer Biology

Program Overview

The cancer biology graduate degree program—jointly administered by The Wistar Institute and University of the Sciences (USciences)—trains individuals with outstanding potential for a successful academic or industrial career in cancer biology and drug development.

This comprehensive, integrated cancer biology graduate program is centered on the involvement of Wistar faculty and USciences faculty and provides an inclusive, broad-based graduate educational venue that complements and expands existing opportunities for cancer training in the greater Philadelphia area. Successful candidates will be granted a Ph.D. in cancer biology from University of the Sciences.

This integrated program provides a learning experience like no other:

1. The program fills a regional gap in specific training in cancer biology, including cutting-edge strategies in translational aspects, such as cancer prevention and therapy.

2. The program emphasizes the process of drug discovery, including hands-on training at the Molecular Screening Facility.

3. Together with lectures about intellectual property and commercialization, the curriculum equips students to succeed in a multidisciplinary environment as both hypothesis-driven academic cancer researchers and industrial or academic discoverers.


The Wistar Institute gratefully acknowledges generous support for the Cancer Biology Graduate Program from the Cigna Foundation, the Scholler Foundation, and the Christian R. and Mary F. Lindback Foundation.